Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate if pregabalin is effective in treating neuropathic
(nerve) pain resulting from peripheral nerve trauma due to a traumatic or surgical event such
as, for example, motor vehicle accident, fall, sports injury, knee or hip replacement, hernia
repair, thoracotomy, mastectomy, focal/localized burns or crush injury.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.